Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-11-17
2009-12-15
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S373100
Reexamination Certificate
active
07632854
ABSTRACT:
Compounds which are indazole derivatives and pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them, as well as combinatorial libraries of indazole derivatives, as set forth in the specification, are disclosed; these compounds or compositions may be useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
REFERENCES:
patent: 6620831 (2003-09-01), Lee et al.
Brill Wolfgang
Martina Katia
Chung Susannah
Pfizer Italia S.r.l.
Scully , Scott, Murphy & Presser, P.C.
Shameem Golam M. M.
LandOfFree
Aminoindazole derivatives active as kinase inhibitors,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoindazole derivatives active as kinase inhibitors,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoindazole derivatives active as kinase inhibitors,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088493